Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes
Burford stock jumps after jury orders Apple to pay $5.7B in damages to plaintiff (BUR:NYSE)
Nvidia boosts share buyback by record $150 billion
Cathie Wood Goes Big on Nvidia After $150 Billion Buyback, Sells $110 Million of AMD: ARK Invest Also Pic
Nutanix recognised as a leader in Gartner Magic Quadrant for Distributed Hybrid Infrastructure